The first in human trials already show potential benefit for functional outcomes https://t.co/cjyasTB79u, and rodent models suggest we could target cognitive outcomes - all relevant for quality of life
1,107 followers
238 followers
RT @KarlPfleger: Phase 1 safety trial of senolytic combo D+Q (dasatinib + quercetin) for IPF (idiopathic pulmonary fibrosis) just published…
31,072 followers
RT @KarlPfleger: @agingdoc1 @eBioMedicine Pretty disappointing in 2 ways: (1) Science is slow. Why did it take just over 4 years to go from…
3,402 followers
Phase 1 safety trial of senolytic combo D+Q (dasatinib + quercetin) for IPF (idiopathic pulmonary fibrosis) just published (https://t.co/bsRjcg8ozZ). The good: no huge safety issues. But I'm disappointed by how long it took & not seeing the same benefi